Lansoprazole Capsule, Delayed Release
Product Images NDC 68788-8621

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 68788-8621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Delayed-release Cap Usp 30mg (Bottle Label 30mg)

Lansoprazole Delayed-release Cap Usp 30mg (Bottle Label 30mg)
This is a description of Lansoprazole Delayed-Release Capsules, a medication used for gastrointestinal conditions. Each capsule contains 30mg of Lansoprazole, a generic for Prevacid. The capsules are manufactured by Xiromed, LLC. The recommended storage temperature is 20° to 25°C (68° to 77°F). The capsules are white and blue in color, imprinted with "Lansoprazole Delayed-Release Cap. USP 30mg."*
FDA Label Image

Figure-1.jpg (Figure 1)

Figure-1.jpg (Figure 1)
This data table shows the mean severity of daytime heartburn based on the study day for evaluable patients. The severity levels are categorized as 3=Severe, 2=Moderate, 1=Mild, and 0=None. The table includes results for the placebo group, as well as two different dosages of Lansoprazole (15 mg QD and 30 mg QD). The values represent the percentage of patients experiencing each severity level at different time points from the start of treatment.*
FDA Label Image

Figure-2.jpg (Figure 2)

Figure-2.jpg (Figure 2)
This information presents the mean severity of night heartburn for evaluable patients during a study. The severity is ranked on a scale of 0 to 3 (0=None, 1=Low, 2=Moderate, 3=Severe), and data is provided for different treatments including Placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD over the study days. The data includes values for different days from the start of treatment.*
FDA Label Image

Formula-structure.jpg (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.